NCT06583083
- Conditions
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Explore clinical trials studying Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type trial results
NCT06314334
- Conditions
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- Locations
-
- Cancer Hospital of Fujian Province Fuzhou, Fujian, China
- Nantong Cancer Hospital Nantong, Jiangsu, China
- Shanghai Eye Ear Nose and Throat Hospital，Fudan University Shanghai, Shanghai Municipality, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06376721
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Liang Wang Beijing, Beijing Municipality, China
NCT05058755
- Conditions
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- Locations
-
- Xinhua Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT03936452
- Conditions
- Anlotinib, Early Stage, Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, +5 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
NCT03618238
- Conditions
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- Locations
-
- Xinhua Hospital Shanghai, China